Panelists at the recent J.P. Morgan Healthcare Conference in San Francisco, CA were charged with separating the hype from the reality in the field of diagnostics and offered insight into what products will win in the space.
IVD - Industry Insight
A recent scientific statement by the American Heart Association shines a spotlight on cardiovascular genomic testing and gives a nod to two such technologies that are currently on the market.
Medtech startup RenovaCare has developed a device to spray stem cells on burn injuries in an effort to regrow new skin. Here's the latest on the company's progress.
IBSchek, a blood test, can offer a diagnosis of irritable bowel syndrome without the long wait time and high costs of the conventional exclusionary pathway.
In addition to recommendations, guidance, and emergency use authorizations, FDA wants to do more to support development of Zika diagnostic tests.
On January 10, PricewaterhouseCoopers, the California Healthcare Institute, and BayBio released preliminary findings of its California Biomedical Industry 2012 Report from a survey of biomedical industry CEOs. The findings were released at a panel discussion with three CEOs active in the healthcare space: Rick Winningham, CEO of Theravance Stephen Cary, CEO of Omniox Alex Lukianov, CEO of Nuvasive MD+DI will provide a recap of the CEOs' reflections soon.